DUSA Pharmaceuticals (DUSA)

5.43 +0.03  +0.56%  May 25, 5:21PM Go Pro
Watch this stock
View Full Chart DUSA Price Chart

Key Stats

Market Cap 133.85M
Revenue Growth 22.21%
Profit Margin -2.51%
Earnings Yield 5.34%
Dividend Yield 0.00%
Earnings Per Share TTM 0.29
PE Ratio 18.72
Price / Sales Ratio 2.804
52 Week High 6.83
52 Week Low 3.25
Beta 0.8576
View Pro Ratings Details

YCharts Pro Ratings

Go Pro.
Learn More
  • Pro Value Score Go Pro
  • Pro Fundamental Score Go Pro
  • Pro Valuation from Historical Multiples Go Pro

News

May 17 $DUSA - Initial Stop hit. Trade close @ Initial Stop of $5.10 - http://stks.co/3so5 by TraderFoxxx
May 15 DUSA PHARMACEUTICALS INC Financials
May 10 $DUSA forms bearish "Diamond Top" chart pattern. http://stks.co/3mUY by RecogniaEvents
May 09 New Star Analyst Rankings for DUSA Pharmaceuticals, Inc.
May 08 $DUSA filed latest Quarterly Report http://stks.co/3j1g by MarketBrief
May 08 DUSA PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report
May 08 Listen to $DUSA Q1 2012 earnings call - live at 08:30 AM, ondemand after - http://stks.co/3iR7 by earningscast
May 08 Q1 2012 DUSA Pharmaceuticals Earnings Release - 06:30 am ET
May 08 DUSA Pharmaceuticals (DUSA) Tops Q1 EPS by 1c Street Insider
May 08 DUSA Pharmaceuticals Reports First Quarter 2012 Corporate Highlights and Financial Re...
Mar 26 Trade Signal-New $DUSA -BTO @ 6.48-Limit w/5.10-Stop on the Wkly Chart w/.5N @ Risk http://chart.ly/t5llhwx by TraderFoxxx

Profile

Exchange: NASDAQGM       Sector: Healthcare       Industry: Drug Manufacturers - Other

1 Year Total Return Performance

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). DUSA Pharmaceuticals is down 11.43% over the last year vs S&P 500 Total Return up 2.57%, Allos Therapeutics down 20.67%, and Gentium down 9.20%.

  • DUSA Total Returns
  • ^SPXTR Total Returns
  • ALTH Total Returns
  • GENT Total Returns

Fundamentals

Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.

Income Statement View Statement

Get Quote for

Pro Strategies Featuring DUSA

Did DUSA Pharmaceuticals make it into our Pro Portfolio Strategies?

Start your YCharts Pro membership now to find out.

DUSA Charts

Recent Quotes

Symbol Price Chg Chg % Market Cap
DUSA 5.43 +0.03 +0.56% 128.92M
DUK 21.96 +0.16 +0.73% 28.90B
DUCK 8.02 -0.31 -3.72% 30.80M
DTV 46.41 +0.04 +0.09% 31.23B
DTSI 28.06 +0.29 +1.04% 459.59M
DTE 56.56 +0.11 +0.19% 9.506B
DSX 8.25 +0.27 +3.38% 669.64M
DSPG 6.11 +0.16 +2.69% 134.33M
DRYS 2.29 +0.04 +1.78% 945.69M
DRW 24.86 +0.00 +0.00%
You must be signed in to use watchlists.
Sign In or Register
Create Watchlist from Stock Quotes
Close